Iteos Therapeutics Inc (ITOS) — Financial Flexibility Index
Iteos Therapeutics Inc (ITOS) has a Financial Flexibility Index of -0.33x as of June 2025. Free cash flow of $-42.16 Million (operating CF $-42.45 Million minus capex $283.00K) represents 0% of total liabilities ($129.28 Million). Check ITOS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Iteos Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Iteos Therapeutics Inc across 7 annual periods. See Iteos Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Iteos Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Iteos Therapeutics Inc. For the full company profile including market capitalisation, see ITOS stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-96.55 Million | $-98.18 Million | $96.68 Million | ▲ +8.5% |
| 2023 | -1.09x | $-100.79 Million | $-103.76 Million | $92.36 Million | ▲ +9.3% |
| 2022 | -1.20x | $-110.25 Million | $-111.19 Million | $91.66 Million | ▼ -177.6% |
| 2021 | 1.55x | $514.32 Million | $513.14 Million | $331.89 Million | ▲ +233.4% |
| 2020 | -1.16x | $-24.82 Million | $-25.18 Million | $21.36 Million | ▲ +21.9% |
| 2019 | -1.49x | $-22.42 Million | $-23.14 Million | $15.07 Million | ▲ +2.7% |
| 2018 | -1.53x | $-18.87 Million | $-19.10 Million | $12.34 Million | — |